002252.SZ
上海莱士
SZSE · Healthcare · C 制造业 · CN
CNY 4.81
−0.21%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.9B | 7.3B | 8.2B | 8.0B | 6.6B |
| Cost of Revenue | 4.3B | 4.6B | 4.9B | 4.7B | 3.7B |
| Gross Profit | 2.5B | 2.7B | 3.3B | 3.2B | 2.9B |
| Operating Expenses | |||||
| R&D Expense | 234.7M | 223.4M | 250.9M | 173.7M | 145.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 490.3M | 469.1M | 459.7M | 379.0M | 333.4M |
| Selling & Marketing Expense | 339.0M | 334.8M | 408.1M | 333.8M | 373.0M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.1B | 1.0B | 1.1B | 832.6M | 843.7M |
| Cost and Expenses | 5.4B | 5.6B | 6.0B | 5.5B | 4.5B |
| Operating Income (EBIT) | 1.6B | 1.9B | 2.7B | 2.2B | 2.3B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 1.6B | 1.9B | 2.6B | 2.2B | 2.3B |
| Income Tax Expense | 285.0M | 328.9M | 426.3M | 426.7M | 400.6M |
| Bottom Line | |||||
| Net Income | 1.3B | 1.6B | 2.2B | 1.8B | 1.9B |
| Earnings from Cont. Ops | 1.3B | 1.6B | 2.2B | 1.8B | 1.9B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.3B | 1.6B | 2.2B | 1.8B | 1.9B |
| Per Share | |||||
| Basic EPS | CN¥0.20 | CN¥0.24 | CN¥0.33 | CN¥0.27 | CN¥0.28 |
| Diluted EPS | CN¥0.20 | CN¥0.24 | CN¥0.33 | CN¥0.27 | CN¥0.28 |
| Revenue Per Share | CN¥1.04 | CN¥1.12 | CN¥1.23 | CN¥1.21 | CN¥0.98 |
| Shares | |||||
| Basic Shares Outstanding | 6.6B | 6.6B | 6.6B | 6.6B | 6.7B |
| Diluted Shares Outstanding | 6.6B | 6.6B | 6.6B | 6.6B | 6.7B |
| Profitability Metrics | |||||
| EBITDA | — | 2.2B | 2.9B | 2.4B | 2.5B |
| D&A | — | 237.4M | 215.6M | 169.9M | 190.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026